STK39 (STLK3 ), actif, son humain étiqueté, PRECISIO, recombinant, exprimé en cellules bactériulovirus infectées par Sf9 ,>=70% (SDS-PAGE), solution de glycérol aqueuse tamponnée

Code: srp5288-10ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

STK39 (also known as serine threonine kinase 39) is involved in the cellular stress response pathway. STK39 is activated in response to hypotonic stress l...


en savoir plus

Votre prix
$517.74 10UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

STK39 (also known as serine threonine kinase 39) is involved in the cellular stress response pathway. STK39 is activated in response to hypotonic stress leading to phosphorylation of several cation-chloride-coupled co-transporters. STK39 activates the p38 MAP kinase pathway and its interaction with p38 decreases during cellular stress. STK39 acts as an intermediate in the response to cellular stress. STK39 is also an independent risk factor for hypertension in men and its intragenic SNPs can interact and function in the control of blood pressure.

Legal Information

PRECISIO is a registered trademark of Sigma-Aldrich Co. LLC

Physical form

Supplied in 50 mM sodium phosphate, pH 7.0, 300 mM NaCl, 150 mM imidazole, 0.1 mM PMSF, 0.2 mM DTT, 25% glycerol.

Preparation Note

After opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles.

assay≥70% (SDS-PAGE)
formbuffered aqueous glycerol solution
Gene Informationhuman ... STK39(27347)
mol wt~63 kDa
NCBI accession no.NM_013233
product linePRECISIO®
recombinantexpressed in baculovirus infected Sf9 cells
shipped indry ice
specific activity17.6-26.4 nmol/min·mg
storage temp.−70°C
Ce produit répond aux critères suivants: